Does BELATACEPT Cause Focal segmental glomerulosclerosis? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Focal segmental glomerulosclerosis have been filed in association with BELATACEPT (NULOJIX). This represents 0.4% of all adverse event reports for BELATACEPT.
13
Reports of Focal segmental glomerulosclerosis with BELATACEPT
0.4%
of all BELATACEPT reports
1
Deaths
5
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From BELATACEPT?
Of the 13 reports, 1 (7.7%) resulted in death, 5 (38.5%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELATACEPT. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does BELATACEPT Cause?
Off label use (304)
Death (206)
Transplant rejection (178)
Cytomegalovirus infection (142)
Drug ineffective (142)
Product storage error (142)
Acute kidney injury (137)
Covid-19 (129)
Hospitalisation (123)
Kidney transplant rejection (97)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which BELATACEPT Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
BELATACEPT vs BELIMUMAB
BELATACEPT vs BELINOSTAT
BELATACEPT vs BELUMOSUDIL
BELATACEPT vs BELVIQ
BELATACEPT vs BELZUTIFAN